RFX1 Regulates Immune Microenvironment and Predicts Immunotherapy Response in Colon Cancer: A Multi-Omics and Clinical Analysis
A nomogram model based on RFX1 combined with pTMB provides an alternative approach for the diagnosis and treatment of colon cancer.
Authors
- Chenying Liu (ORCID: https://orcid.org/0009-0004-5743-0092)
- Wenbo Tang (ORCID: https://orcid.org/0000-0002-5103-2999)
- Xiaoyong Ge
- Yan Liu (ORCID: https://orcid.org/0000-0002-2566-6867)
- Zhongchuan Wang (ORCID: https://orcid.org/0000-0003-0179-4343)
- Zhujiang Dai
Institutions
- XinHua Hospital (CN)
- Shanghai Cancer Institute (CN)
Publication Details
- Journal
- Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
- Published
- 2025-01-01
- DOI
- https://doi.org/10.32604/or.2025.068473
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00